• Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

  • May 26 2022
  • Length: 27 mins
  • Podcast

Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

  • Summary

    • Overview of olipudase alfa
    • Efficacy and safety of olipudase alfa from phase 2 and 3 trials
    Show more Show less

What listeners say about Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.